2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
13
Motor Activity
5
Colorectal Neoplasms
5
Smoking Cessation
4
Neoplasms
4
Lung Neoplasms
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Smoking
2
Prostatic Neoplasms
2
Papillomavirus Infections
2
Colonic Neoplasms
2
Behavior
2
Skin Cancer Prevention
1
Polycystic Ovary Syndrome
1
Patient Compliance
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Other Cancer
1
Obesity
1
Melanoma
1
Medication Adherence
1
Lymphedema
1
Gastrointestinal Neoplasms
1
Colorectal Cancer Screening
1
Chronic Pain
1
Body Weight Changes
1
Body Weight
1
Anxiety Disorders
1
Interventions
Gemcitabine
685
130-nm albumin-bound paclitaxel
199
Fluorouracil
190
Oxaliplatin
177
Albumin-Bound Paclitaxel
154
Capecitabine
137
Leucovorin
133
Irinotecan
114
Radiotherapy
96
Taxes
85
pembrolizumab
81
Cisplatin
73
Erlotinib Hydrochloride
70
Radiosurgery
69
Nivolumab
56
Drug Therapy
56
Bevacizumab
54
Magnetic Resonance Spectroscopy
51
Cyclophosphamide
50
folfirinox
45
Specimen Handling
43
Docetaxel
42
Cetuximab
40
Biopsy
39
irinotecan sucrosofate
38
S 1 (combination)
36
Pancreaticoduodenectomy
35
Blood Specimen Collection
34
Surgical Procedures, Operative
31
Paclitaxel
30
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
Motivational Interviewing
×
Clear all
NCT05162846
2026-03-09
MiGHT
University of Michigan Rogel Cancer Center
Phase NA
Completed
831 enrolled